Spotlight Innovation Inc. (fka STLT)

[Ecomike]

News is out on STLT, they have signed a deal for the second part of Phase I drug trial for cancer for the top Cletic drug.

http://ih.advfn.com/p.php?pid=nmona&article=67801626&symbol=STLT

Item 1.01 Entry into a Material Definitive Agreement.



Effective July 14, 2015 Spotlight Innovation Inc.'s (the "Company") subsidiary Celtic Biotech Inc. ("Celtic") entered into a Clinical Study Management Agreement (the "Agreement") with ImmunoClin Ltd. ("ImmunoClin") whereby ImmunoClin is to conduct, on behalf of Celtic the second part of the study Open Label Phase I Clinical Trial of Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration" (the "Study"). Pursuant to the Agreement the timing of the Study is expected to be 18 months, and Celtic has agreed to pay ImmunoClin an aggregate of Euro 525,330 ($576,865 USD based on current conversion rates) payable in installments (as defined in the Agreement) during the course of the Study.



The foregoing summary of Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, copy of which is filed as an Exhibit to this Current Report on Form 8-K and is incorporated herein by reference.